Is It COVID-19? The Flu?
THE BIOFIRE RP2.1plus PANEL MENU
Overall 97.1% Sensitivity and 99.3% Specificity 1
Sample Type: Nasopharyngeal swab in transport media
BioFire’s Syndromic Testing Has Been Shown To:
Request a BioFire System Demo
Are you ready to order the BioFire System or want to request a free demo? Click below to take the next step towards faster results with syndromic infectious disease testing.
- The stated performance is based on the prospective portion of the clinical study as described in the BioFire® Respiratory 2.1plus Panel Instructions for Use.
- The COVID Tracking Project. The Atlantic. Available from: https://covidtracking.com/data.
- BioFire® Syndromic Trends.
- Martinez, et al. Geisinger Health System (CVS poster, May 2016).